Advisory Board

Back row: Martin Gurbin (VP, Sunnybrook International), Dr. David Young, MD (Managing Partner, Actium Capital Advisors), Neil Maresky (VP, Scientific Affairs, AstraZeneca), Dr. Jayson Parker (Medical Biotech Analyst, MBiotech), Grant Tipler (Head, Life Science & Healthcare Markets, RBC), Ian Grant (President, Pioneer Hi-Bred Limited).

Front Row: Helen Filipe (Administrative Director, Corporate & Student Development, MBIotech), Allan O'Dette (Director, External Relations & National Private Markets, GlaxoSmithKline), Professor Scott Prosser (Director, MBiotech), Dr. Ulrich Krull (Vice-Prinicipal, Research, UTM), Dr. Leigh Revers (Associate Director, MBiotech), Gord Surgeoner (President, Ontario Agri-Food Technologies).

Absent: Dr. Neil Berinstein, MD (Sunnybrook Odette Cancer Centre), Paul Bradley (VP, Strategic Affairs, Johnson & Johnson), Stephen Dibert (CEO, MEDEC), Dr. Peter Kalinka (Head of Biopharmaceuticals, Apotex).